Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 1,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Healthy
Interventions: Medium chain triglycerides, Long chain triglycerides; Dietary Supplement
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pregnancy, Sexually Transmitted Diseases
Interventions: Interactive multimedia platform, Intervention arm counseling, Standard of care counseling; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 709 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Healthy
Interventions: ExPEC4V (4 : 4 : 4 : 4), ExPEC4V (4 : 4 : 4 : 8), ExPEC4V (8 : 8 : 8 : 8), ExPEC4V (8 : 8 : 8 : 16), ExPEC4V (16 : 16 : 16 : 16), Placebo; Biological · Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 848 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 17
States / cities: Mesa, Arizona • Hollywood, Florida • Leesburg, Florida + 14 more

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Placebo, 100mg SPN-812, 200mg SPN-812, 300mg SPN-812, 400mg SPN-812; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Maitland, Florida

Conditions: Alzheimer Disease
Interventions: Ketogenic Diet, Therapeutic Lifestyles Changes Diet; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 50 Years to 90 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Fairway, Kansas

Conditions: Motor Function, Cognitive Function, Contrast Media
Interventions: Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain, Gadolinium Measurements, Gadoxetate disodium, Gadobenate dimeglumine, Gadodiamide, Gadoterate meglumine, Gadobutrol, Gadoteridol; Procedure · Drug
Lead sponsor: Guerbet; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 2,076 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 16
States / cities: Scottsdale, Arizona • New Haven, Connecticut • Chicago, Illinois + 11 more

Conditions: Tobacco Use
Interventions: Tobacco power wall size and tobacco products displayed; Behavioral
Lead sponsor: RAND; Other
Eligibility: 11 Years to 20 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm
Interventions: Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Thyroid Eye Disease
Interventions: AMG 732, Placebo; Drug · Other
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 12
States / cities: Little Rock, Arkansas • Newport Beach, California • Jacksonville, Florida + 9 more

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: FG-3019; Drug
Lead sponsor: Kyntra Bio; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 4
States / cities: Denver, Colorado • Ann Arbor, Michigan • Dallas, Texas + 1 more

Conditions: Type 1 Diabetes
Interventions: T1CARE; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura
Interventions: ARC 1779 Placebo, ARC1779 Injection; Drug
Lead sponsor: Archemix Corp.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 7
States / cities: Chicago, Illinois • Indianapolis, Indiana • St Louis, Missouri + 4 more

Conditions: Concussion, Brain, Sleep Disorder
Interventions: Brief Sleep Intervention; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hypothermia
Interventions: NeoWrap, InfaTherm; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 24 Weeks to 28 Weeks
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Smoking Status
Interventions: Control, Media Literacy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 13 Years to 18 Years
Enrollment: 1,211 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: McKeesport, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Skin Cancer
Interventions: Sun Safety Social Media Challenge, Digital Health Social Media Challenge; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 30 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Psoriasis
Interventions: D-2570 Tablet, Placebo Tablets; Drug
Lead sponsor: InventisBio Co., Ltd; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 20
States / cities: Birmingham, Alabama • Phoenix, Arizona • Chula Vista, California + 16 more

Conditions: Colorectal Cancer, Prevention
Interventions: On-site Fecal Immunochemical Test (FIT) Kit Distribution, On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 45 Years to 75 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Omaha, Nebraska

Conditions: Overweight (BMI > 25), Obesity (BMI>30), Hs-CRP
Interventions: Avocado, Control; Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 21 Years to 74 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Las Vegas, Nevada

Conditions: Contrast Enhanced Computed Tomography
Interventions: 20GA BD Nexiva Diffusics, 18GA Conventional Catheter; Device
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 18 Years and older
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Second-degree Burn
Interventions: Mepilex Ag (burn dressing), Xeroform Dressing; Device
Lead sponsor: Wayne State University; Other
Eligibility: 7 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Urinary Incontinence, Stress Incontinence, Female, Urge Incontinence
Interventions: Social Media Navigation Aid Kit; Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Albuquerque, New Mexico • Rio Rancho, New Mexico

Conditions: Carotid Artery Plaque, Arteriosclerosis, Obesity, Metabolic Syndrome X
Interventions: Rimonabant, Placebo (for Rimonabant); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 661 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Respiratory Syncytial Virus Infections
Interventions: RSVPreF3 OA investigational vaccine (GSK3844766A); Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 60 Years and older
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Lenexa, Kansas • Elkridge, Maryland • Omaha, Nebraska + 4 more

Search by objective public record fields.

MiCrobiome dieT Study

Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens

A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

Therapeutic Diets in Alzheimer's Disease

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Shrinking the Size of the Tobacco Power Wall

Patient Considerations of Social Media Account Management After Death

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Addressing Sleep in Adolescents Post-Concussion ("ASAP Study")

Warming Mattress Versus Polyethylene Wrapping to Prevent Hypothermia in Preterm Newborns.

Media Literacy to Prevent Adolescent Smoking

Social Media Indoor Tanning Study

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans

Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury

Social Media Navigation Aid Kits for Urinary Incontinence

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study